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Abstract 
THE IDENTIFICATION AND LOCALIZATION OF THE ABELSON 
ONCOPROTEIN IN ZEBRAFISH, (Danio rerio) 
(December 2010) 
Richard Charles de Triquet, B.S., Belmont Abbey College 
M.S., Appalachian State University 
Chairperson:  Susan L. Edwards, Ph.D. 
 
The ubiquitously expressed Abelson oncoprotein (Abl) has multiple molecular functions, 
which affect homeostasis and cytoskeletal structuring of the cell. Mutation of the Abl 
gene is the causal event in several types of leukemia and is linked to the progression of 
certain lung and breast cancers. Despite extensive literature documenting the protein’s 
function in humans and the recent explosion of cancer research using zebrafish, no 
research to date has investigated the existence of an Abl ortholog in Danio rerio.    
We have sequenced a cDNA clone from D. rerio that demonstrates high identity 
to other vertebrate Abl proteins. In addition, we have investigated expression of the abl 
gene from 2-48 hours post fertilization (hpf) by in situ hybridization. The abl gene is 
expressed beginning at 12 hpf in the polster, a region of future brain development, and 
expression at this site continues through 48 hpf. Weaker expression is seen throughout 
the midsagittal line of the body at earlier stages and in the midsection and tail at later 
stages of the pharyngula period. Expression of the abl protein in zebrafish, examined by 
immunohistochemistry, is seen in the posterior blood island from 24-32 hpf. 
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Together, these results suggest that putative zebrafish abelson homolog has 
multiple functions in early development, aiding in the differentiation of neuronal cells in 
the central nervous system and also facilitating the production and differentiation of 
hematopoietic progenitor blood cells in the posterior blood island beginning at 24 hpf.  
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Introduction 
 
 The Abelson (Abl) oncoprotein performs an array of cellular functions that affect the 
homeostatic characteristics of the cell. Although the protein is ubiquitous in all cell types 
(Sirvent, Benistant, & Roche, 2008), its most deleterious effects can be found within blood 
cells where it was discovered 50 years ago. In 1960, Peter Nowell and David Hungerford 
discovered a shortened chromosome 22 that was consistently found within the blood cells of 
patients diagnosed with chronic myeloid leukemia (CML) (Nowell & Hungerford, 1960). 
The disease causes increased proliferation of the myeloid cell lineage (Daley, Vanetten, & 
Baltimore, 1990), which includes granulocytic cells and monocytes (Parham, 2005). The 
discovery of a consistent genetic mutation linked to a specific oncogenic progression was the 
first of its kind and spawned decades of intensive research focused on discovering the 
molecular activity of the Abl protein. 
 Investigations by Janet Rowley in 1973 established that the shortened chromosome 
22 found in CML patients was the result of a translocation with chromosome 9 (Rowley, 
1973), while later studies confirmed that this reciprocal translocation involved the Abl gene 
on the long arm of chromosome 9 and the Bcr gene on the long arm of chromosome 22 (see 
Figure 1) (Shtivelman, Lifshitz, Gale, & Canaani, 1985). The mutated chromosome was 
named the Philadelphia chromosome after the city of its discovery (Druker, 2008), and 
contains the Bcr-Abl fusion gene, which produces a constitutively active fusion kinase. It is 
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produced in a hematopoietic stem cell (HSC) and after HSC division it can be found in 
myelocytes, megakaryocytes, erythrocytes, and small lymphocytes (Daley et al., 1990). Bcr-
Abl causes malignant transformation of HSCs and hematopoietic progenitor cells through 
altered cellular adhesion, inhibition of apoptosis, and stimulation of mitogenic pathways 
resulting (Daley et al., 1990; Deming et al., 2004; Gross & Ren, 2000; McGahon et al., 
1997). This specific fusion kinase is present in >95% of patients with CML, ≈20% of adult 
acute lymphoblastic leukemia patients (Gross & Ren, 2000; Kurzrock, Kantarjian, Druker, & 
Talpaz, 2003; Reinhold, Hennig, Leiblein, Niederwieser, & Deininger, 2003; Shtivelman et 
al., 1985), and ≈5% of pediatric acute lymphoblastic leukemia patients while fusion of Abl to 
the Tel gene results in T-cell acute lymphocytic leukemia (Srinivasan, Sims, & Plattner, 
2008). Major headway was made in 2001 when the Food & Drug Administration approved 
the use of a tyrosine kinase inhibitor that was able to shut down Abl kinase activity, 
effectively reversing the progression of CML (Druker, 2008).  
 Despite this momentous medical triumph, a subset of patients still develop resistance 
to the kinase inhibitor and all patients harbor a persistent population of Bcr-Abl positive 
blood cells within the major adult site of hematopoiesis: the bone marrow (Jin et al., 2009; 
Reinhold et al., 2003). HSCs in inactive states reside within the endosteal niche of the bone 
marrow and adhere to thrombopoietin producing osteoblasts cells (Yoshihara et al., 2007). 
When stimulated, these cells can migrate to microvascular subregions immediately adjacent 
to osteoblasts where stromal cell derived factor-1 chemokines are expressed (Sipkins et al., 
2005). These vascular subregions can harbor residual leukemic cells, including Bcr-Abl 
positive cells, following clinical treatment suggesting that this microenvironment stimulates 
anti-apoptotic characteristics in cells residing there (Sipkins et al., 2005). For these reasons, 
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investigations in Homo sapiens, Mus musculus, and Drosophila have continued with the 
ultimate goal of fully understanding the normal and altered molecular activity of the Abl 
kinase within all types of cells, especially hematopoietic cells.   
 
The Abl tyrosine kinase 
The Abl gene encodes for a non-receptor tyrosine kinase that is localized within the nucleus 
and cytoplasm (Plattner, Kadlec, DeMali, Kazlauskas, & Pendergast, 1999; Sirvent et al., 
2008; Sun et al., 2000; Wetzler et al., 1993). It represents one of 32 different non-receptor 
tyrosine kinases in the human kinome that are stimulated by cytokines, growth factors, and 
receptors (Sirvent et al., 2008). In humans, there are four major Abl isoforms that are similar 
in structure to Bcr-Abl, v-Abl and the related c-Src tyrosine kinase (see Figure 2) (Sirvent et 
al., 2008). The Abl1a and Abl1b isoforms (c-Abl) and the Abl2a and Abl2b isoforms (Arg1a 
and 1b) have a molecular weight of 145 kilodaltons (kD). Following the N-terminus, all 
isoforms contain a Cap region, the SH3, SH2, and Kinase domains (Koleske et al., 1998; 
Plattner et al., 1999; Sirvent et al., 2008). Abl1a and Abl2b isoforms possess N-terminal 
myristolation (Sirvent et al., 2008). All isoforms contain a polyproline (PXXP) rich region 
following the Kinase domain, which interacts with the Abl SH3 domain when inactive and 
with the SH3 domain of other proteins when active, thus aiding in protein interactions 
(Plattner et al., 1999; Sirvent et al., 2008). Both Abl1 isoforms contain nuclear localization 
signals and a DNA binding domain essential for nuclear functions (Plattner et al., 1999; 
Sirvent et al., 2008). Abl2 isoforms contain the DNA binding domain but are absent of 
nuclear localization signals indicative of cytoplasmic function (Plattner et al., 1999; Sirvent 
et al., 2008). For all isoforms, the remaining portion of the C-terminus end contains a 
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globular actin (G-actin) binding domain, a filamentous actin (F-actin) binding domain, and a 
nuclear export signal essential for cytoplasmic migration (Plattner et al., 1999; Sirvent et al., 
2008).  
The v-Abl isoform (Abelson murine leukemia virus) is a cellular homologue of Abl1 
and contains an altered N-terminus with deletion of the SH3 domain (Daley et al., 1990; 
Sirvent et al., 2008). The mutated form of the Abl kinase contains the addition of the Bcr 
region adjacent to the SH3 domain causing the deletion of the N-terminus Cap region and 
myristolation site in Abl1b and Abl2b isoforms (Sirvent et al., 2008). Bcr-Abl proteins with 
weights of 190, 210, and 230 kD occur with breaks occurring at different exons of the Bcr 
gene prior to translocation (Kurzrock et al., 2003). These isoforms are strictly localized to the 
cytoplasm and display increased activity (Sirvent et al., 2008). 
Activity of the Abelson tyrosine kinase is contingent on binding with substrate 
proteins, which facilitates phosphorylation of those substrates. This action occurs within the 
Kinase domain of Abl through transfer of a terminal phosphate group from adenosine 
triphosphate (ATP) to a tyrosine residue on the substrate protein (see Figure 3) (Sirvent et al., 
2008). Phosphorylation by Abl occurs through numerous partners allowing it to propagate a 
suite of signals (Druker, 2008). The type of signal depends on the specific isoform and the 
cellular location. Similar to other kinases, Abl configuration and activity is tightly regulated 
(Plattner et al., 1999); regulation is achieved by interaction of the SH2, SH3, and Kinase 
domains to maintain the Abl in the closed inactive conformation (see Figure 4) (Sirvent et al., 
2008). The N terminus interacts with a pocket on the C-lobe of the kinase domain to 
strengthen the closed shape (Sirvent et al., 2008). Consequently, loss of the N-terminus 
results in constitutive activation (Kurzrock et al., 2003). Phosphorylation at the activation 
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loop (Y245) and the linker region (Y412) effectively causes the protein to assume an open 
conformation and become active (see Figure 4) (Kurzrock et al., 2003). Normal 
phosphorylation at these sites is controlled by motifs in the N-terminal of Abl so loss of this 
region to Bcr fusion causes altered phosphorylation and constitutive activation (Kurzrock et 
al., 2003). 
 
Cellular functions 
Abl isoforms display different molecular functions in both the nucleus and cytoplasm 
and can shuttle between the nucleus and cytoplasm for activity in multiple locations (Sirvent 
et al., 2008). Within the nucleus, Abl1 isoforms respond to DNA damage through a variety of 
proteins including P75, P73 P53, STAT3, and HS1 (Agami, Blandino, Oren, & Shaul, 1999; 
Gong et al., 1999; Lapetina, Mader, Machida, Mayer, & Koleske, 2009; Sirvent et al., 2008; 
Srinivasan et al., 2008; Sun et al., 2000). When interacting with P53 or P73 tumor suppressor 
proteins, Abl1 can halt the cell cycle at the G1 phase and initiate apoptosis (Agami et al., 
1999; Sun et al., 2000). Alternatively, it can promote G1 to S phase progression and 
proliferation in breast cancer cells through STAT3 (Srinivasan et al., 2008).  
 Cytoplasmic functions are involved with cytoskeletal structure, an important feature 
in regulation of cell shape, cell movement, and cell-to-cell interactions. Cytoplasmic Abl 
activation can promote DNA synthesis, F-actin assembly and receptor trafficking (Sirvent et 
al., 2008). In other cells, the proliferative capacity of Abl is induced by platelet-derived 
growth-factor (PDGF) and directly activated by phosphorylation at Y412 and Y245 through 
the Src family kinases (Plattner et al., 1999; Sirvent et al., 2008; Srinivasan & Plattner, 2006; 
Srinivasan et al., 2008). Activation triggers Abl association with cortactin and F-actin 
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resulting in cortactin phosphorylation and F-actin polymerization (Plattner et al., 1999). The 
resulting F-actin polymerization is required for proper cytoskeletal structuring of 
lamellipodia, filopodia, dorsal ruffles, and neurite extensions (Boyle, Michaud, Schweitzer, 
Predki, & Koleske, 2007; Plattner et al., 1999; Sirvent et al., 2008). Circular dorsal ruffling, a 
structural feature linked to macro-pinocytosis and cell migration is commonly observed in 
leukocytes (Plattner et al., 1999; Sirvent et al., 2008). In addition, dorsal ruffle formation by 
Abl activation can also be linked to increased invasion of several breast cancer cell lines 
(Srinivasan & Plattner, 2006; Srinivasan et al., 2008). 
Within specific leukocyte lineages Abl isoforms have been implicated in stimulation 
proliferation and apoptotis. The B cell inhibitory Fc receptor is dependent upon Abl1 
signaling in the stimulation of B-cell apoptosis (Tzeng, Bolland, Inabe, Kurosaki, & Pierce, 
2005). In T cells, receptor stimulation results in activation of Abl kinases leading to IL-2 
production and T cell proliferation (Zipfel, Zhang, Quiroz, & Pendergast, 2004). Abl1 is also 
required for actin polymerization and lamellipodial spreading at the immune synapse in T 
and B cells, a feature necessary for engagement of the T and B cell receptor to antigens, cell-
to-cell contact, and effective T-cell migration (Huang et al., 2008; Lapetina et al., 2009). 
 Abl’s role in various hematopoietic processes is evident by the malignant 
transformation of HSCs containing the Bcr-Abl protein. Normal forms of Abl are also 
involved with a number of homeostatic processes within the cell that affect the survival of 
the cell and cytoskeletal structure allowing interaction with the extracellular environment. 
These functions raise many questions concerning the role of Abl in the migration, structure, 
and differentiation of diverse cell types during embryonic development. Despite a multitude 
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of documented Abl functions, there are still large gaps of missing information and no 
research to date has been published linking the Abl tyrosine kinase and zebrafish.  
 
Zebrafish 
 The Abl functions discussed thus far have been researched in humans and established 
animal models, but we aim to investigate the possible functions in Danio rerio. The 
zebrafish, a valuable model of early development, hematopoiesis, and cancer is an ideal 
candidate for modeling human disease based on its small size, ease of breeding, ex-utero 
development of embryos and transparency of those embryos (Meeker & Trede, 2008; Yoder, 
Nielsen, Amemiya, & Litman, 2002). Most importantly, the large number of orthologous 
genes that zebrafish share with mice and humans allow further investigation of Abl 
functioning. One area of research that still deserves greater attention is the role that Abl plays 
in embryonic development. Abl1 and Abl2 double knockout in mice proves lethal at 
embryonic day 9, demonstrating that the proteins are essential during early development 
(Koleske et al., 1998). Abl has also been implicated in the development of axonal outgrowths 
in Drosophila (Plattner et al., 1999) and proper construction of the central nervous system in 
Mus musculus (Koleske et al., 1998); thus, it is possible that Abl may be involved with 
zebrafish neurogenesis. It is also relevant to examine the role of Abl in the early 
establishment of hematopoiesis. We know that mutation can cause established hematopoiesis 
to go awry. However, possible functions the kinase may have in the establishment of 
definitive hematopoiesis and its role in early hematopoietic progenitor cells is not known. 
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Hematopoiesis 
 Zebrafish are known to have many hematopoietic homologies with humans due to the 
evolution of the adaptive immune system prior to the divergence of fish from other 
vertebrates (Meeker & Trede, 2008). Accordingly, zebrafish are known to produce nearly all 
of the same blood cell types as humans with the main difference between the two species 
being the sites of blood cell maturation during development (Meeker & Trede, 2008). 
Currently, there are many blood related diseases being modeled by zebrafish: MOZ/TIF2-
induced acute myeloid leukemia (Zhuravleva et al., 2008), heat shock induced T-cell 
lymphoma (Feng et al., 2007), Notch1-induced T-cell leukemia (Chen et al., 2006; Sharma et 
al., 2006), Myc-Induced T Cell leukemia (Langenau et al., 2002), and B-cell chronic 
lymphocytic leukemia (Auer, Riaz, & Cotter, 2007). This is possible due to many 
hematopoietic homologies. One identifying characteristic of vertebrate hematopoiesis is the 
presence of HSCs within various anatomical regions during different waves of blood cell 
production (Jin et al., 2009).  
During early development, vertebrate hematopoiesis progresses in successive waves 
that occur in several different organs (Murayama et al., 2006). The first wave, or primary 
wave, gives rise to the most immediately needed blood cell types both developing in the yolk 
sac: erythrocytes containing embryonic globin proteins (Davidson & Zon, 2004; Kalev-
Zylinska et al., 2002) and macrophages (Samokhvalov, Samokhvalova, & Nishikawa, 2007; 
Willett, Cortes, Zuasti, & Zapata, 1999; Zapata, Diez, Cejalvo, Frias, & Cortes, 2006). These 
two cell types are essential in oxygenating and remodeling embryonic tissue (Bertrand et al., 
2007). Appearance of these blood cells in zebrafish coincides with the initiation of 
circulation at 24 hours post fertilization (hpf) (Isogai, Horiguchi, & Weinstein, 2001). Based 
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on these findings, the yolk sac has been regarded as a primitive hematopoietic organ, not 
capable of producing definitive blood cell types such as lymphocytes and myeloid cells.  
But recent studies have also shown that this region can also contain progenitor cells, 
which differentiate to produce definitive blood cell types in hematopoietic colony assays 
(Orkin & Zon, 2008; Samokhvalov et al., 2007; Weissman, 1978). Other studies have shown 
that cells migrating from the yolk sac express Runx1 which codes for a transcription factor 
essential for HSC emergence, when the yolk sac is the sole hematopoietic site (Bertrand et 
al., 2007; Samokhvalov et al., 2007). These cells can be traced and later contribute to 
definitive hematopoiesis; about 1-10% of adult HSCs have origins in the yolk sac in murine 
studies (Samokhvalov et al., 2007). Studies in zebrafish show that hematopoietic cells arising 
from the yolk sac generate an erythromyeloid progenitor (EMP) that migrates to the aorta-
gonad mesonephros (AGM) region (Bertrand et al., 2007). HSCs also emerge directly in the 
AGM, (Jin et al., 2009; Orkin & Zon, 2008; Samokhvalov et al., 2007) and the ventral wall 
of the dorsal aorta shortly after the onset of circulation and express the HSC associated 
genes, c-myb and runx1 (Bertrand et al., 2007; Davidson & Zon, 2004; Jin et al., 2009; 
Murayama et al., 2006). It is commonly held that definitive hematopoiesis begins with HSC 
production in the AGM and their migration to later hematopoietic sites (Bertrand et al., 2007; 
Murayama et al., 2006; Murry & Keller, 2008), where they produce a diversified blood cell 
repertoire (Bertrand et al., 2007; Murayama et al., 2006). EMPs in the zebrafish AGM do 
migrate to a region in the tail where they later produce erythroid and myeloid cells (Bertrand 
et al., 2007). But, HSCs in the AGM are not totally dormant and do give rise to myeloid cells 
in zebrafish between 28-48 hpf suggesting that the AGM is a hematopoietic site which does 
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contribute to the blood cell repertoire and is more than just a transition zone for HSCs on 
their way to subsequent niches (Bertrand et al., 2007; Jin et al., 2009). 
HSCs in zebrafish migrate to the ventral tail region from 24-48 hpf and display the 
presence of several genes including c-myb, runx1, lmo, and mpx, which are all known to 
participate in hematopoiesis within humans (Bertrand et al., 2007); in addition, these cells 
also display the presence of the transcription factor pu.1, a powerful factor essential in 
myeloid and lymphoid cell development (Hsu et al., 2004; Ward et al., 2003). This region 
termed the posterior blood island (PBI) is also referred as caudal hematopoietic tissue (CHT), 
and the intermediate cell mass (ICM) at earlier stages. The fetal liver within humans and the 
PBI within zebrafish serve as an intermediate site of hematopoiesis during development 
following cell production in the AGM (Orkin & Zon, 2008). In zebrafish, HSCs in this 
region migrate from the PBI to the kidney, which is the adult site of hematopoiesis (Orkin & 
Zon, 2008). It is not known whether this type of HSC migration occurs in humans, but HSCs 
begin to appear in the fetal liver and bone marrow at roughly the same time (Orkin & Zon, 
2008). HSCs in the fetal liver differentiate into common myeloid progenitors (CMPs) and 
common lymphoid progenitors (CLPs), but display less restrictive lineage commitment (Jin 
et al., 2009). The CLPs in this region can give rise to lymphoid cells and macrophages 
(Mebius et al., 2001). It is probable that some HSCs from the liver migrate to the marrow and 
that HSCs emerge in the marrow de novo (Orkin & Zon, 2008).  
The shifting location of HSCs throughout development has consequences on the their 
differentiation repertoire and potential due to niche influence on HSC (Jin et al., 2009).  
Although the precise origin of HSCs leading to definitive hematopoiesis is debated, it is 
known that cells with progenitor capacity can be found in the yolk sac, the AGM, fetal liver, 
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and bone marrow of humans. In zebrafish, progenitor cells can be observed in the yolk sac, 
AGM, PBI, and kidney. The presence of hematopoietic cells within multiple regions at 
various stages in development is consistent with the notion that the hematopoietic potential 
of progenitor cells changes as the primary site of hematopoiesis shifts. 
The presence of similar blood cells and genes and their development emphasize 
hematopoietic homologies present in zebrafish. These conserved hematopoietic mechanisms 
allowing a variety of blood based cancers to be modeled in the organism supporting the 
possibility of finding an active Abl gene in the fish. Moreover, the Abl gene is evolutionarily 
conserved across disparate organisms including nematodes, flies, mice and humans 
(Henkemeyer, West, Gertler, & Hoffmann, 1990). 
 
Purpose of study 
The long-range goal of this research was to characterize the expression of the putative 
Abelson gene and protein during early embryonic development in zebrafish. Our working 
hypothesis was that an ortholog of the human Abl protein is active in zebrafish functioning in 
multiple aspects of hematopoiesis including cell growth, proliferation, and migration. The 
three main objectives of this research were to clone and sequence cDNA obtained from D. 
rerio tissue homologous to human Abl, examine expression of the Abl mRNA in D. rerio by 
whole-mount in situ hybridization (ISH) from 2-48 hpf, and determine the temporal and 
spatial expression of the Abl protein during early hematopoiesis by whole-mount 
immunohistochemistry (IHC) and western blot techniques. 
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Methods 
 
Zebrafish husbandry and embryo collection 
  Zebrafish were housed in a Z-Mod system (Aquatic Habitats) and maintained at 28°C 
on a 16 hour light / 8 hour dark cycle. Breeding of adult AB line fish was facilitated in 
specialized mating chambers, which allowed for subsequent embryo collection. Embryos 
were staged according to a staging series based on morphological features (Kimmel, Ballard, 
Kimmel, Ullmann, & Schilling, 1995) and fixed overnight in 4% paraformaldehyde (PFA) 
prior to de-chorionation and dehydration in methanol for use in ISH and IHC. For western 
blot studies, embryos staged at 18, 24, 32, and 36 hpf were snap frozen in liquid nitrogen and 
stored at -80°C. The Appalachian State University IACUC approved all procedures involving 
the use of zebrafish.  
 
cDNA clone sequencing and sequence analysis 
 A Danio rerio cDNA clone was purchased through Open Biosystems (clone ID: 
3857626, Accession: EB951650). The gene was subcloned into a pSport1 vector and 
propagated in the DH5α bacterial strain. Plasmid DNA for sequencing reactions and ISH was 
isolated by a PureYield Plasmid Maxiprep System (Promega, Madison, WI).  Primers were 
designed by MacVector11.0 and ordered (Eurofins MWG Operon, Hunstville, AL) for use in 
sequencing reactions (see Table 1). Cornell Life Sciences Core Laboratories Center and 
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Mount Desert Island Biological Station performed sequencing reactions. The obtained 
sequence was translated with the ExPASy proteomics server 
(http://ca.expasy.org/tools/dna.html) and aligned with other sequences using ClustalW2 
(http://www.ebi.ac.uk/Tools/ clustalw2/index.html). Phylogenetic tree analysis was 
completed with Phylogeny.fr (http://www.phylogeny.fr/) using MUSCLE 3.7 for multiple 
sequence alignment, GBlocks 0.91b for alignment refinement, PhyML 3.0 aLRT for 
phylogeny, and TreeDyn 198.3 for tree rendering (Dereeper et al., 2008). Amino acid 
sequences from Abl1 orthologs, predicted Abl1orthologs, and Bcr-Abl were used for 
multiple sequence alignments and phylogenetic tree construction: translation of Danio rerio 
cDNA clone (EB951650), predicted Danio rerio v-Abl1 homolog (XP_001337899.1), Homo 
sapiens (NP_005148.2), Mus musculus (NP_001106174.1), Rattus norvegicus 
(ABC46642.1), Bcr-Abl fusion kinase (ABX82702.1), Pongo abelii (XP_002833232.1), 
Equus caballus (XP_001917300.1), Xenopus (Silurana) tropicalis (XP_002936228.1), 
Strongylocentrotus purpuratus (XP_001203875.1). 
 
Whole-mount in situ hybridization 
Plasmid DNA was linearized separately by either a Not1 or Sal1 restriction digest, 
purified with a DNA clean and concentrator kit (Zymo Research, Orange, CA), its 
concentration determined by NanoDrop, and checked for linearization by gel electrophoresis. 
A digoxigenin (DIG) RNA labeling Kit was used for RNA labeling with DIG-UTP by in 
vitro transcription using SP6 and T7 RNA Polymerase (Roche, Indianapolis, IN). Plasmid 
DNA cut with Sal1 was transcribed with SP6 promoters for Antisense (AS) experimental 
probes. Plasmid DNA cut with Not1 was transcribed using T7 promoters for Sense (S) 
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negative control probes. The transcription reaction contained 10x transcription buffer, DIG 
labeled nucleotides, RNAse inhibitor, T7 or SP6 polymerase, 1ug of cut plasmid DNA, and 
DEPC-H20 to bring to a 20 ul volume. These reactions were incubated at 37°C for 2 hours, 
template DNA was removed by incubation with DNAse I recombinant (Roche, Indianapolis, 
IN) at 37°C for 30 min. Transcribed probes were then precipitated overnight using 4M 
Lithium Chloride and 100% Ethanol. Efficiency of DIG-RNA transcription was checked by 
gel electrophoresis and concentration of RNA probe determined by NanoDrop. 
Within 24-well plates, embryos were progressively rehydrated to 0.1% PBS Tween 
(PBT), permeabolized with Proteinase K at stage dependent times according to (Thisse & 
Thisse, 2008) and incubated in 4% PFA for 20 min. Embryos were then pre-hybridized at 
70°C for 5 hr in hybridization mix (HM) at a final pH of 6.2 containing 50% formamide, 
5xSSC, 50 ug/ml heparin, 500 ug/ml torula yeast, and 0.1%Tween. After pre-hybridization, 
embryos were incubated at 70°C overnight in HM containing 50 ng of AS or S probe per 
well respectively for experimental and negative controls. The following day, embryos were 
washed with 2X and 0.2X SSC, progressively brought to PBT, and then incubated in 
BSA:PBT:5% sheep serum at room temperature for 1 hour. Embryos were then incubated at 
4°C overnight with an anti-DIG-alkaline phosphatase antibody (α-DIG-AP) (Roche, 
Indianapolis, IN) at a 1:2000 concentration. The next day, embryos were washed with PBT 
and any bound α-DIG-AP antibodies were visualized by a staining reaction with NBT/BCIP 
color development substrate. A Meiji compound microscope fitted with a Leica DFC320 
digital camera and the Leica Application Suite Version 3.3.1 program was used for picture 
acquisition.  Images were compiled using Microsoft PowerPoint 2008 for Mac. 
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 Whole-mount immunohistochemistry 
 Fixed, staged embryos were rehydrated to PBS and non-specific binding sites were 
blocked by incubation in blocking solution at room temperature for 30 min. Blocking 
solution contained 50 ul/ml Normal Goat Serum (NGS), 6.7 ul/ml triton, and 940 ul/ml PBS. 
Embryos were incubated with 1:100 primary antibody at 4°C overnight; negative controls 
were kept in blocking solution at 4°C during that time. The sc-131 primary antibody (Santa 
Cruz Biotechnology, Santa Cruz, CA) used in protein studies was a polyclonal rabbit 
antibody specific to the kinase domain of human Abl1. The following day, embryos were 
washed with 0.1% PBS triton and incubated for 1 hour at room temperature with 1:1000 
goat-α-rabbit-AP antibody (Bio-Rad, Hercules, CA). Bound antibody was stained by 
NBT/BCIP reaction and visualized by techniques used in ISH. 
 
K562 cell culture and whole cell extract 
K562 cells, a CML cell line containing the Bcr-Abl fusion kinase (Amar et al., 1992), 
were incubated in filter sterilized Iscove base media containing heat inactivated fetal calf 
serum (Atlanta Biologicals, Lawrenceville, GA) sodium-pyruvate, L-glutamine, and 
penicillin-streptomycin solution.  Cells were incubated at 37°C at 5% CO2. Approximately 2 
x 107 cells were collected and re-suspended in an eppendorf tube containing 500 ul of PBS. 
Cells were spun for 10 s at 13,200 RPMs. PBS was aspirated and cell pellet was re-
suspended in 150 ul of freeze-thaw buffer (F-T) containing 250M tris-HCl at pH8, 10mM 
dithithreitol, and 15% glycerol. Cells in F-T buffer were frozen in liquid nitrogen then 
thawed in a 37°C water bath and repeated for a total of four freeze thaw events. The sample 
was centrifuged at 10,000 RPM at 4°C for 5 min and the supernatant containing whole cell 
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extract was quantified for protein concentration using a bicinchoninic acid protein assay kit 
(Thermo Fisher Scientific, Rockford, IL).  
 
Western blot 
Snap frozen zebrafish embryos were homogenized in a buffer solution; 
homogenization buffer had a final pH of 7.8 and contained sucrose, tris base, 100mM EDTA, 
phenylmethylsulfonyl fluoride and protease inhibitor cocktail. Homogenized samples were 
centrifuged at 14,000 RPM at 4°C for 10 min and supernatants were collected for protein 
quantification according to a bicinchoninic acid protein assay kit (Thermo Fisher Scientific, 
Rockford, IL). Protein from K562 cells and staged zebrafish embryos were used for positive 
and experimental controls respectively. 
Twenty-five ug of K562 cell protein and 75 ug of zebrafish protein at 18, 24, 32, and 
36 hpf was loaded into NuSep 4-20% LongLife gels for electrophoresis at 50v for 30 min and 
90v until completion (≈1 hour). Protein was then blotted onto Bio-Rad Immun-Blot PVDF 
membranes for 1 hr at 100v. Non-specific binding sites were blocked by incubation in blotto 
at room temperature for ≥ 5 hours; blotto contained 5 g of carnation non-fat powdered milk 
and 100 ml TBS with 0.2% triton. For experimental and positive controls, membranes were 
then incubated in 1:200 sc-131 primary antibody at 4°C overnight. Negative controls were 
incubated at 4°C overnight in sc-131 antibody pre-absorbed with sc-131 peptide (4:1 
concentration of peptide: antibody). The following day membranes were washed in TBST; 3 
x 15 min. TBST at a final pH of 7.4 contained 1.21 g/L tris base, 8.76 g/L NaCl, and 2 ml/L 
of triton. Following TBST washes, membranes were incubated in 1: 3000 goat-α-rabbit-AP 
antibody (Bio-Rad, Hercules, CA) for 1 hour, and stained by NBT/BCIP reaction. Membrane 
 
17 
images were procured using an Epson Stylus NX400 Series scanner and compiled for figures 
by using the program Microsoft PowerPoint 2008 for Mac.                                         
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Results 
 
Sequencing of cDNA 
After sequencing the cDNA clone (ID: 3857626, Accession: EB951650) that was 
listed as a mRNA sequence of 737 base pairs (bp) by OpenBiosystems, it was discovered that 
it was actually a 3893 bp clone containing a translatable region of 332 amino acids (aa). The 
remaining 2897 bp following the translatable region contained numerable stop codons. Our 
clone was incomplete at the 5’ end but did contain and a poly-a tail at the 3’ end. A protein 
BLAST analysis using the NCBI database identified two predicted Danio rerio v-Abl1 
oncoprotein homologs: isoform1 (XP_001337829.1) and isoform2 (XP_001337899.1), which 
respectively are 1079 aa 1060 aa in length. These sequences had 99% identity when pairwise 
aligned with the translatable region of our cDNA clone. The 5’ portion of the predicted D. 
rerio v-Abl1 homolog and our sequenced clone has been compiled to show a tentative full 
length abl mRNA sequence (see Figure 5). Base pairs 1-2290 represent the predicted 
sequence available online (XM_001337793.3). The following 996 bp (base pairs 2291-3287) 
region represents the translatable region of our clone and displays corresponding codons 
above. The blue underlined portion indicates the sequence transcribed during the generation 
of DIG-RNA probes; single underlined portions of both colors (blue and black) correspond to 
the areas we have sequenced. Colored boxes highlight the primers used for sequencing.  
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When the 332 aa translatable region was aligned with other annotated Abl1 
sequences, we observe a pairwise alignment score of 51 to H. sapiens Abl1.  However, when 
the full length predicted D. rerio v-Abl1 sequence (XP_001337899.1) is used, the pairwise 
alignment score increased to 71 when compared to H. sapiens Abl1. The deduced amino acid 
sequence was aligned with other known Abl1 sequences and the Bcr-Abl form of human 
origin (see Figure 6). A phylogenetic tree comparing the predicted D. rerio Abl 
(XP_001337899.1) and other Abl1 homologs was also constructed (see Figure 7). 
 
Whole-mount in situ hybridization 
I have examined expression of the abl gene using in situ hybridization at embryonic 
stages from the cleavage and blastula period to late pharyngula just prior to hatching. 
Embryos at the following stages were examined: 2, 12, 18, 24, 32, 36, and 48 hpf. There was 
no expression of the abl gene at 2 hpf; both positive and negative controls are absent of 
NBT/BCIP staining (see Figure 8A).  
Expression begins to appear at 12 hpf during the bud stage and was observed in 
several regions of the developing neural plate: anteriorly in the deepest regions of the polster 
closest to the midsagittal furrow where prechordal plate hypoblast accumulates, within the 
posterior region of the neural plate at the site of early somite development, and within the 
tailbud (see Figure 8B-E). Expression is strongest in the polster with lighter staining seen in 
the posterior regions of the neural plate and tail bud. At 18 hpf, expression is concentrated at 
the polster (see Figure 9A-C). Ventral view shows that abl expression in concentrated in the 
deepest areas of the polster closest to the midsagittal furrow with minimal expression seen 
within the tailbud (see Figure 9C).  
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Expression is anteriorly localized at 24 hpf, (see Figure 9D,E). Expression is also 
seen through the midsection of the body strengthening mildly at the tail and PBI (see Figure 
9D,F). A similar pattern is seen at 32 hpf with the strongest expression in the head and 
expression continuing through the midsection and into the tail and PBI (see Figure 9G-J). At 
36 hpf, expression is concentrated in the head and dissipates abruptly where somite 
segmentation begins (see Figure 10A,C). Light expression is seen along regions of tail 
immediately above the notochord (see Figure 10A, B, D).   
At 48 hpf, expression of abl is diffuse along the midline of the tail and midsection 
and splits immediately above the center of the yolk sac into a Y shaped pattern with 
expression in the head concentrating at regions between the developing eyes (see Figure 
10G). Intense expression in the head corresponds to areas of the future eye, telencephalon 
and midbrain and within the endoderm deepest to the yolk sac (see Figure 10F). Expression 
of abl is not seen in negative controls using the sense RNA probe (see Figure 11).  
 
Whole-mount immunohistochemistry 
I have also examined protein expression of Abl using the SC-131 antibody specific 
for the kinase domain of human Abl1 at the following embryonic stages: 18, 24, and 32 hpf. 
At 18 hpf there is minimal protein expression concentrated in the tail bud (see Figure 12A). 
Stronger expression is seen within the PBI and caudal vein plexus at 24 hpf and 32 hpf (see 
Figure 12 C,E). There is intense staining at the tail tip and at a region anteriorly adjacent to 
the tail tip at 24 hpf (see Figure 12C). Negative controls were absent of any staining (see 
Figure 12B,D,F) 
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Western blot 
A western blot with zebrafish embryonic protein at 18, 24, 32, and 36 hpf was 
conducted with the sc-131 antibody. A band of slightly >100 kD is present in lanes 1-4 
corresponding to embryos at 18-36 hpf (see Figure 13A). Expression is greatest at earlier 
time stages and progressively diminishes in strength at later time stages. The molecular 
weight is congruous with the predicted molecular weight of D. rerio v-Abl1 (117 kD); 
therefore, it is likely that this band represents the Abl homolog. It is also evident that there 
are multiple bands present at molecular weights too small to be considered Abl protein. 
Figure 13B contains the addition of the K562 positive control in lane 1 with lanes 2-5 
corresponding to embryos at 18-36 hpf. Lane 1 contains bands within the range 150-250 kD 
which is also in agreement with the known Bcr-Abl molecular weights of 190, 210, and 230 
kD (Amar et al., 1992). However, this lane also contains other bands of incorrect weights.  In 
a pre-absorption negative control (4:1 peptide: antibody concentration), all bands diminish in 
strength but are still present (see Figure 13C).  
 
 
22 
Discussion 
 
Data at the DNA, RNA, and protein level obtained in this research allow several 
conclusions to be made concerning the existence of an Abl homolog in zebrafish. Sequencing 
of a D. rerio cDNA clone, translation by ExPASy, and subsequent protein blast searches 
return abl homologs in humans, mice, and a variety of other organisms. A predicted D. rerio 
Abl protein 99% identical to our clone has 71% identity to Abl1 of human origin indicating 
homology. The predicted D. rerio v-Abl1 and v-Abl2 isoforms, which are publicly available 
on the NCBI database, contain a C-terminus with F-Actin and G-Actin binding sites, the 
Kinase domain, and the SH2 domain.  Due to the high similarity of zebrafish DNA sequences 
and the presence of conserved domains, these results suggest that the zebrafish Abl protein 
could have similar cytoskeletal functions based on its C-terminus binding sites. In addition to 
sequence analysis, RNA investigations validate the possibility of an Abl homolog in 
zebrafish.  
The segmentation period in zebrafish is a key time when the brain rudiment is being 
sculptured (Kimmel et al., 1995). Prior to this segmentation period, during the 64-cell stage 
at 2 hpf we observed an absence of abl gene expression. However, beginning at 12 hpf, abl 
gene expression was seen anteriorly in the deepest regions of the polster closest to the 
midsagittal furrow where the prechordal plate thickens (Kimmel et al., 1995). This 
thickening region of the neural plate occurs at the animal pole and is caused by the 
accumulation of prechordal plate hypoblast; it represents the site of future brain and eye
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development. Expression of the abl gene was present here within the midsagittal furrow from 
12-48 hpf.  This furrow, caused by the formation of brain rudiment, contained abl expression 
linking the gene with neural plate formation and morphogenesis of the neural rod (see Figure 
9C) (Kimmel et al., 1995) indicating that it is active during these time stages.  
In the brain of adult mice, Abl2 is found in high amounts and co-localizes with Abl1 
during neurulation, indicating the involvement of Abl in embryonic neurogenesis (Koleske et 
al., 1998). Studies in Drosophila and Mus musculus have demonstrated the importance of the 
Abl gene in axon guidance and synapse formation in the developing central nervous system 
(Lin et al., 2009; Stevens et al., 2008). These proteins are also highly active in retinal cells of 
Drosophila (Henkemeyer et al., 1990). Our zebrafish embryos showed strong expression in 
the eye region from 24-48 hpf and within sites corresponding to development of brain tissue. 
Our results, in accordance with the literature suggest that abl has a function in the 
development of the central nervous system and eyes of the embryonic zebrafish from 12-48 
hpf. 
 Another key avenue of investigation is the involvement of abl in hematopoiesis. Its 
function in zebrafish hematopoiesis can be examined by observing two regions: the AGM 
and PBI. Both regions are known to harbor hematopoietic progenitor cells beginning at 24 
hpf and peaking at 30 hpf. In zebrafish, HSCs are present in the AGM from 28-48 hpf and 
contain several genes involved in hematopoiesis (Bertrand et al., 2007); the gene and protein 
expression patterns of abl that we have observed are similar to patterns discussed in the 
literature. Within the tail, we see strongest expression at 24 and 32 hpf and a decrease in tail 
expression of abl at 36 hpf. In addition, presence of abl transcripts and peptides in the PBI 
was strongest at 24-32 hours (see Figure 9F,I) linking abl to the emergence or migration of 
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HSCs in the AGM. Occurring around 22 hpf, studies also show that myeloid cells group in 
the rostral region of the embryo and are scattered around the margins adjacent to the yolk 
sac. Embryos at 24 hpf showed staining clustered around the yolk sac but it is undetermined 
whether this staining represents myeloid cell grouping (see Figure 9). Expression at these 
sites adjacent to the yolk sac may represent abl function in hematopoiesis or neurulation. It is 
possible that regions in the head represent neurulation functions and regions closer to the 
sinous venosus and mid section represent myeloid cell clustering.  
Transcripts of abl were found along the midline of the body above the yolk sac 
extension and the tail at 48hpf. This expression could represent abl presence in the dorsal 
aorta, a site of HSC emergence. The gene may be involved in the development of HSCs at 
this region. Expression of the gene split into a Y shape displaying lateral arms pointing 
towards the head when dorsally viewed; this split in the expression pattern is consistent with 
the splitting of the dorsal aorta into the lateral dorsal aortas at the sinus venosus of the heart. 
After branching, the lateral dorsal aortas supply the primitive internal carotid artery which 
line the inner margins of the developing eye (Isogai et al., 2001); abl may be involved with 
vascular formation of these vessels. However, immediately above these two vessels lie the 
primordial hindbrain channel and the primordial midbrain channel (Isogai et al., 2001). 
Expression within these veins would block the view of the underlining lateral dorsal aortas so 
it is unclear if abl is expressed in these vessels or the deeper lateral dorsal aortas.  
  Protein studies are consistent with RNA expression in the PBI at 24 hpf and 32 hpf. 
Both ISH and IHC identify abl expression within this region immediately posterior to the 
yolk sac extension at times correlating to emergence of the EMP and production of 
erythrocytes and monocytes. However, expression of the abl protein within the head regions 
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does not match our previously described localization of abl gene expression. In western blot 
studies, pre-absorption of the primary antibody with peptide did not completely compete out 
bands of correct molecular weight (see Figure 13C). All bands, of correct or incorrect weight, 
were partially competed out indicating two possible situations: the primary antibody was pre-
absorbed with an inadequate concentration of peptide, or that the primary antibody is not 
highly specific to the abl1 protein. Future protein studies will require the use of a monoclonal 
antibody and peptide to produce definitive results. 
Through the sequencing of the zebrafish genome, we can now examine specific 
sequence identities shared with humans. There was a highly identical sequence within the 
fish and we have potentially identified it as an Abl ortholog. We examined this ortholog on 
several levels by cDNA clone sequencing, RNA in situ hybridization, and protein 
immunohistochemistry. This multifaceted investigation revealed the presence of abl in sites 
of central nervous system development and early definitive hematopoiesis at corresponding 
time points. Temporal and spatial expression indicates that the abl protein is expressed within 
the PBI during the emergence of the erythromyeloid progenitor and other HSCs. Based on 
these results it is probable that the abl tyrosine kinase in zebrafish has multiple cellular 
functions in the early morphogenesis of the fish. In other species, Abl serves multiple 
functions during embryonic development and specific roles later (Sirvent et al., 2008). 
Finally, many of Abl’s known molecular partners have been identified and examined in 
zebrafish: p73, p53, HS1 and the src kinase family are all active in the fish indicating the 
possibility of abl kinase actions in zebrafish regulatory networks. 
  Our investigations of the Abl gene and protein in combination with the existing 
literature support the existence of conserved hematopoietic and neurogenic functions of Abl 
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in zebrafish. This protein, if mutated to produce a Bcr-Abl isoform, could become oncogenic 
providing possible direction for further research of the Abelson tyrosine kinase’s molecular 
activity in zebrafish. Future studies to definitively establish Abl homology in zebrafish would 
entail the use of a monoclonal antibody for IHC and western blots. This antibody would be 
expected to completely compete out protein bands with correct molecular weight. 
Additionally, it would be pertinent to examine gene and protein expression at later stages in 
development and conduct tissue sectioning to more effectively establish localization. Several 
studies could be conducted to examine the functionality of the abl gene and protein in 
zebrafish: link abl to a green fluorescent protein to examine in vivo expression, knockdown 
abl expression to address how essential it is in early development, and co-localize abl with 
genes and proteins of known function in zebrafish.  
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Table  1.  Primers  used  for  cDNA  clone  sequencing.  Primers were designed with 
MacVector and ordered through Eurofins MWG Operon. Sequencing  reactions  involving 
the Danio rerio cDNA clone (ID: 3857626) were performed by Cornell Life Sciences Core 
Laboratories Center and Mount Desert Island Biological Station. 
 
Primer Name  Nucleotide Sequence 
5A  5’-TCTGGAAAGACCTCAAGGAG-3’ 
5B  5’-TCCGCAGGACTTCTCAAAGC-3’ 
5C  5’-CCATTTGCCGTTTCACAC-3’ 
3A  5’-CTACACCAAAAACCACATCG-3’ 
3B  5’-GCAAATGGTGCTTTAGGC-3’ 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(Druker, 2008) 
 
Figure  1. The Philadelphia chromosome. The Abl gene originating on the long arm of 
chromosome 9 becomes translocated onto the long arm of chromosome 22 at the break point 
cluster region (Bcr gene). This creates a shortened chromosome 22, the Bcr-Abl fusion gene, 
and a lengthened chromosome 9. A portion of the Bcr gene is also translocated to 
chromosome 9 (Druker, 2008). 
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(Sirvent et al., 2008) 
 
Figure  2. Isoforms of the Abelson protein.  A variable N-terminus is followed by a Cap 
(certain isoforms), the SH3, SH2, and Kinase domains. In addition, a PXXP (proline rich 
sequences), a NLS (nuclear localization signals), a DNA binding domain, a G-Actin, and a F-
Actin binding domain are found in some isoforms. The mutated Bcr-Abl isoform and the v-
Abl isoform contain the addition of the BCR and GAG domains, respectively.  This results in 
the loss of the variable N-terminus. Phosphorylation sites resulting in Abl activation are 
indicated by red circles (Sirvent et al., 2008). 
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(Druker, 2008) 
 
Figure  3. The molecular activity of the Bcr-Abl tyrosine kinase. When the tyrosine 
kinase and substrate protein are properly bound, a phosphate group (PO4) from ATP is 
transferred to a tyrosine (TYR) residue on the substrate protein producing ADP and 
substrate protein activation. This action is completed in the same molecular manner 
within all Abl isoforms, but with varying strengths (Druker, 2008). 
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(Sirvent et al., 2008) 
 
Figure 4. Inactive and active conformations of c-Abl. The binding of the N-terminal end 
with a pocket on the C-lobe kinase, SH2 to the C-lobe of the Kinase domain, and SH3 to 
the linker region keeps Abl in a closed shape. Phosphorylation at the SH2 domain, Y245, 
Y412, or loss of the N-terminus causes Abl to assume an open conformation and become 
activated (Sirvent et al., 2008). 
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1 atggggcagc 
11 agccaggaaagttagtgggtgagcagaggagaccgagcctgccggcactgcccttcatca 
71 aggccgcggggaggagagagacgccccggcacggagcaccgcactgcaatgtgttcacgg 
131 tccacgagtctcggccggatttcgatccccccggtctttcagaagcggcgcgctggaact 
191 ctaaagagaacctgctgtcgggacccagcgaaaatgaccccaatctgttcgtggcgctgt 
251 acgactttgtggcgagcggcgacaacactctcagcataactaaaggagagaagctgaggg 
311 ttctgggatacaatcacaatggtgagtggtgcgaggcgcagaccaagaacgggcagggct 
371 gggtgcccagcaactacatcacgcccgtcaacagcctggagaagcacagctggtaccacg 
431 ggccggtgtccagaaatgctgcagagtacctgctgagcagcggcatcaacggcagcttcc 
491 tggtgcgggagagcgagagcagcccgggacagcgctccatatcactgcgctacgagggac 
551 gagtctaccactaccgcattaatacagcctcagacggcaagctgtacgtgtcgtccgaga 
611 gccgctttaacactctagcagagctggttcatcatcactccacggtctctgacggtctga 
671 tcaccacgctgcattaccccgcacccaaacgcaacaaacccaccatctacggcgtctctc 
731 caaactacgacaagtgggagatggagcgcacggacatcaccatgaagcacaagctgggcg 
791 gagggcagtacggggaggtgtacgagggcgtgtggaagaagtacagcctcaccgtggcgg 
851 tgaaaacactgaaggaagacaccatggaagtggaggagtttctgaaagaagctgcagtga 
911 tgaaagaaatcaaacacccaaacctggtgcagctcttaggcgtctgcactcgggaacctc 
971 cgttctacatcatcactgagttcatgacacatggaaacctgctggattacctgcgcgagt 
1031 gtaaccggcaggaggtgaacgctgtggtgctgctctacatggccacgcagatctcctccg 
1091 ccatggagtacctggagaagaagaacttcatccacagggatctggcagcccgtaactgct 
1151 tggtcggggaaaacaacctggttaaagtggcagattttgggctaagccggctgatgacgg 
1211 gagacacatacacagcccacgctggagcaaagttccccattaaatggactgcgccggaga 
1271 gtctggcctataacaagttctccatcaagtcagacgtgtgggcatttggagtcctgcttt 
1331 gggagatcgccacctatgggatgtctccgtatccaggaatcgacctgtctcaggtgtatg 
1391 agctgctggagaaagactaccgcatggacagacccgagggatgcccagagaaagtctatg 
1451 agctcatgagggcctgttggaggtggaaccctgccgagcgcccttcttttgctgagaccc 
1511 atcaggcgttcgagaccatgtttcaagagtccagtatctctgatgaggtggagaaagagt 
1571 tggggaaaaaaggaaagaagctgaccctgggaccaatacagcaggcgccagaacttccaa 
1631 ctaaaaccaggacactacgaagacctacagacggcagggatggggacagtcccgccgagg 
1691 ccgaggtcactggacccccgatgatgccgaggccactcctagatagcaacctgaatgaag 
1751 ccagtctaaagataataaggataaatttcgaatgaatcccttcagttatattaagaaaaa 
1811 gaagaggacggctccggcgcccccaaagcgcagcagctcctttgggaagatggacggaca 
1871 cctagaccgtagaggattgggtactgactgcagggaggatttcagcaacgggtcttccac 
1931 caatgatgccttaaacagcattgacccttgcaaattagttgggtcaaacagtaccacgac 
1991 catcggggtcaccaacggagctccagtgtatcccggtcagctcttcccatctcatccacg 
2051 gaaaaagggcactacatcgggtggtggagggaagcttgccacgactccacctccagagga 
2111 ggactccatgtcaaactccaaacgcttcctacgatcttcttcttcctccagcatgcctcc 
2171 aggctctgatcgcttcgaatggaagtccgtaaccctgccgcgggacattcagtcaacaca 
2231 ccacgcgtccgcacattcagaggcaagccagttttacctcgtaagagctgcatgccacga 
  P  R  V  R  T  F  R  G  K  P  V  L  P  R  K  S  C  M  P  R  
2291 ggtggcacgcttaccccaccaccacgccttcccaagaaaagtgaagatgtttcagacgaa 
  G  G  T  L  T  P  P  P  R  L  P  K  K  S  E  D  V  S  D  E  
2351 gtcttcaaggactctgagtctagtcctggatcaagtcctttaactctgactcccaagcta 
  V  F  K  D  S  E  S  S  P  G  S  S  P  L  T  L  T  P  K  L  
2411 ggccgccgaccccaaacagaaagctccaaaactagtgccttacaaacagaggtattaaaa 
  G  R  R  P  Q  T  E  S  S  K  T  S  A  L  Q  T  E  V  L  K  
2471 cccaatgtgcttccacctcttggagacgaaggcagacctcgaagactcaaactgtcctct 
  P  N  V  L  P  P  L  G  D  E  G  R  P  R  R  L  K  L  S  S  
2531 gaaatcccaggacagagagagcgggagaaggggaagtttgcgaaacccaaacccgctccc 
  E  I  P  G  Q  R  E  R  E  K  G  K  F  A  K  P  K  P  A  P  
2591 cctcctcctccggtgtccagtgccaaatctggaaagacctcaaggagtccgacttttgag 
  P  P  P  P  V  S  S  A  K  S  G  K  T  S  R  S  P  T  F  E  
2651 gtgtcttcagataccaaagtcaagagttcactagactccgcagatcaaggcaaggctagt 
  V  S  S  D  T  K  V  K  S  S  L  D  S  A  D  Q  G  K  A  S  
2711 ctatcccaagaaagtgctaaaaagttgcccaaaaatggctcaaaggtaaacccctcgaag 
  L  S  Q  E  S  A  K  K  L  P  K  N  G  S  K  V  N  P  S  K  
2771 gcaggtgcgactgctcctctacctggaatgggagccagtcctgtggtcggggatccggga 
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  A  G  A  T  A  P  L  P  G  M  G  A  S  P  V  V  G  D  P  G  
2831 tccagcttcatcccactgatgacgacgcgacgttcactgaggaaggctccagcacggcag 
  S  S  F  I  P  L  M  T  T  R  R  S  L  R  K  A  P  A  R  Q  
2891 ccatcagagcgactctccagctccaccatcactcgagacatgctgttggagagctctgag 
  P  S  E  R  L  S  S  S  T  I  T  R  D  M  L  L  E  S  S  E  
2951 ctcctgcgtaccgccattgcacgtgtctccgagcagaccggcagccacagcgctgtcctg 
  L  L  R  T  A  I  A  R  V  S  E  Q  T  G  S  H  S  A  V  L  
3011 gaggcggggaaaaatctgtccaagtactgcgtcagctacgtggagtccatccagcagatg 
  E  A  G  K  N  L  S  K  Y  C  V  S  Y  V  E  S  I  Q  Q  M  
3071 cggaacaagtttgctttccgcgaagccatcaataagctggagagcagcctgcgcgagctg 
  R  N  K  F  A  F  R  E  A  I  N  K  L  E  S  S  L  R  E  L  
3131 cagatctgccccgcggccaccggcaccgcaaacactccgcaggacttctcaaagctgctg 
  Q  I  C  P  A  A  T  G  T  A  N  T  P  Q  D  F  S  K  L  L  
3191 tgctccgtcaaggagatcagcgacatcgtgcagaggtagcagagaacggcgccactggaa 
  C  S  V  K  E  I  S  D  I  V  Q  R  -                       
3251 acacagtatctcgatgtctggggccatgtcttacatttcagttcaacacacctcagctta 
3311 tctcatgccaaatagaggaacgtttgttcagtgtcttattactgtgtgcacaaaaggggg 
3371 aacgtttgatgcggagctgtgctgaggagtaggtcaagaaatcaactctgccactttcaa 
3431 aatgcattgctattctctctggaatctattctgggattggtttttggcagcagtcggcgc 
3491 tctaggctattgtttaacagcagacggcactttaggctagtctttagcagcaaacgctaa 
3551 acccacaatggatcttcctcatgagcattttttgtatagttaaaaactagcctaaagccc 
3611 catctgctgttaaacactagcatagagcgctgtctactgtttgtatcttgcttagagtgc 
3671 catctgctatttaaaactagcctagagcaccatttgccgtttcacacaagcgtagagcgc 
3731 cgtctgccattagacactaacctagagtgccgtctgcaggtaaacactagcctagagtgc 
3791 catttgctgttaaaacaagcctagaccgccctctgctgttaaaaactagtcttgagcgcc 
3851 acctgctgttaaaaaaatagcctagagcgccatctgctgttaaactagcctgaagcacca 
3911 tttgcggtttcaaatgagcgtagaatgccttctgccattaaacactaacctagagcgcag 
3971 tctgcaggtaaacactagcatagagcgtcatctgttgtttaaacaagcctagagtgccat 
4031 ctgccttttaagcactagcctagagcgccatctgcaggtaaacactagtctagagcgcca 
4091 tctgcaggtaaacaccagcctagagcatcatctgttgttaaaacaagcctagagtgccat 
4151 ctgccttttaagcactagcctagagcgccatctgcaggtaaacactagtctagagcatca 
4211 tctgttgctaaagcaagcctagaacgccctctgctgttaaaaaaactaacctagagtacc 
4271 aaccgttgttaaaaaactagtctagagtgtcacctgctgtttatatccagcatagagcgc 
4331 tgtctgctgtttaaaactagtctagagcaccatctgatttttatgtctagccttgagcgc 
4391 catctgctgttaaaaactagcatggagcgctgtctgctgtttatatgtagcctagagcgc 
4451 catctgctatttaaaactagcctaaagcaccatttgccgttttacactagcatagagcgc 
4511 cgtctgccattaaacactaacctagagcgccgtctgctgttaaacactagcctagagaga 
4571 catctgcaggtaagcactagcctagagcgccatctgcaggtaaacactagtctagagcat 
4631 catctgttgctaaagcaagcctagaacgccctctgctgttaaaaaaactaacctagagta 
4691 ccaaccgttgttaaaaaactagtctagagtgtcacctgctgtttatatccagcatagagc 
4751 gctgtctgctgtttaaaactagtctagagcaccatctgatttttatgtctagccttgagc 
4811 gccatctgctgttaaaaactagcatggagcgctgtctgctgtttatatgtagcctagagc 
4871 gccatctgctatttaaaactagcctaaagcaccatttgccgttttacactagcatagagc 
4931 gccgtctgccattaaacactaacctagagcgccgtctgctgttaaacactagcctagaga 
4991 gacatctgcaggtaaacactagcctagagcgtcatctgcaggtaaacactagtctagagc 
5051 gtcatctgttgttaaaacaagcgtagagcgccctctgctgtttaaacacaagcctagagc 
5111 gccatcttctgttgggaattgagctcagaatttatttaaatgagaatattgcatcttgat 
5171 caactctgaatcaatgcgcaatcgatttctcgaacatttcctcgccacagctctgcttcg 
5231 atgttcctctatcatccattcggcgaccctaaaggaactccaggtcgaagtcttcgtgac 
5291 gtgatccttcctgactgtcctctgcattttctcaacgaaaaaggcctgatctcagcgatg 
5351 cagacgattgaaagtgaatcacctcgcgtgcctcgtaattatggaaccagaatctatttt 
5411 gatcacagaatgaaactgatgtagtatttttgcgatgtggtttttggtgtagggtgttat 
5471 ggtgagattgtgaacgctccctgtgatgtgaggaactgctttaagtattgcaacactgtg 
5531 ccacgaacgacatttcacggacaattcagttttattgcgcggtttgtgttcctacacagc 
5591 tttcggcaatgccttagagacacaaatcatcgatcggcgattaaaaaacactactgtctc 
5651 aaggagaaagacttggaggtgtgaaacctgagcttaagaagccgtatatgtatagatgtt 
5711 tttattttaacgttgatttcagactgacggaggagctttaatgaccncactattctgtct 
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5771 taaccagtcttttctcgttgttttgctcgtttagttaaaataatgcccttgttttcagta 
5831 ttagtttgtattttccaacactttgccgtcagactgcgatgcctgaggaggaccncacgc 
5891 tgccttgatttcaacacgccaccagtgttgctgacgtttttatatcttgtcctttagaga 
5951 tcatgccactacttttacatttgtattcaagcctcactttttttaatgctcgtttctgta 
6011 aatacacacttgttttctcctatcggttgattcttcttgtaaccctggtgcaatgtgtgt 
6071 tgcatacaatacagttttgctacttgaacgaaaaaaaaaaaaaaaaaaaaaaa 
 
 
Figure 5. Nucleotide and deduced amino acid sequence of the putative Danio rerio Abelson 
1 homolog. Underlined regions indicate regions we have sequenced from D. rerio cDNA 
(clone ID: 3857626); other regions were obtained from predicted Abl1 homolog on NCBI 
(XM_001337793.3). Blue underlined region indicates translatable region of our clone used in 
protein blasts. Capital letters above nucleotide sequence in the translatable region indicate the 
amino acid sequence. Colored regions indicate site of primers for sequencing reactions. Red 
box and text indicates start and stop codons. 
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Figure 6. Amino acid sequence alignments of Abl1 orthologs and Bcr-Abl. All sequences 
were obtained through the NCBI database: Danio rerio (cloneID:3857626), Homo sapiens 
(NP_005148.2), Mus musculus (NP_001106174.1), Rattus norvegicus (ABC46642.1), Bcr-
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Abl fusion kinase (ABX82702.1). Alignment corresponds to translatable region of the D. 
rerio clone. Alignment was generated using ClustalW2 with the following settings: gap 
opening penalty = 10, gap extension penalty =0.2, protein matrix = Gonnet. Amino acids 
colors indicate basic properties: RED = small + hydrophobic, BLUE = acidic, MAGENTA = 
basic, GREEN =  hydroxyl + amine + basic-Q. “ ★ “ indicates complete conservation and “ : 
” indicates partial conservation of amino acid. 
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Figure 7. Phylogenetic tree of Abl orthologs and Bcr‐Abl. Tree was constructed using  
Phylogeny.fr (http://www.phylogeny.fr/) using MUSCLE 3.7 for multiple sequence 
alignment, GBlocks 0.91b for alignment refinement, PhyML 3.0 aLRT for phylogeny, and 
TreeDyn 198.3 for tree rendering (Dereeper et al., 2008). Branch numbers represent 
percentage of clades grouped following 500 replications. Several species and the Bcr-Abl 
fusion kinase were examined: Danio rerio (XP_001337899.1), Homo sapiens 
(NP_005148.2), Mus musculus (NP_001106174.1), Rattus norvegicus (ABC46642.1), Bcr-
Abl fusion kinase (ABX82702.1), Pongo abelii (XP_002833232.1), Equus caballus 
(XP_001917300.1), Xenopus (Silurana) tropicalis (XP_002936228.1), Strongylocentrotus 
purpuratus (XP_001203875.1). 
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Figure 8. Whole‐mount in situ hybridization of abl expression at 2 and 12 hpf. (A) 2 hpf, 
(B)  12  hpf  embryo  with  polster  indicated  by  black  arrow,  tailbud  indicated  by  blue 
arrow, (C) ventral view at 12 hpf with midsagittal furrow indicated by black arrow, (D) 
12 hpf magnification of polster  from ventral  view,  (E) Posterior  section of  the neural 
plate at 12 hpf. 
 
39 
 
 
Figure 9. Whole‐mount in situ hybridization of abl expression from 18-32 hpf. (A) 18 hpf 
showing expression along the midsagittal furrow, (B) 18 hpf embryo rotated to expose 
dorsal  section of midsaggital  line,  black  arrow  indicates polster,  blue  arrow  indicates 
tailbud,  (C)  18  hpf  ventral  view  showing  expression  at  the midsagittal  furrow,  black 
arrow  indicates  polster,  blue  arrow  indicates  tailbud,  (D)  24  hpf  showing  strong 
expression  in  the  head  and  tail  bud,  (E)  24  hpf magnification  of  head  at,  (F)  24  hpf 
magnification  of  tail,  blue  box  highlights  PBI  region,  (G)  32  hpf  showing  strong 
expression in the head dissipating towards posterior sections, (H) 32 hpf magnification 
of  the  head  showing  strong  expression,  (I)  32  hpf magnification  of  the  tail,  blue  box 
highlights PBI, yellow box highlights AGM region, (J) 32 hpf dorsal view. 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Figure 10. Whole‐mount  in situ hybridization of abl expression at 36 and 48hpf. (A) 36 
hpf  embryo  with  anterior  to  the  left.  Expression  is  strongest  anteriorly  but  some 
expression is observed in the midsection and tail, (B) 36 hpf mid section and yolk sac 
extension  magnification,  (C)  32  hpf  magnification  of  the  head,  (D)  36  hpf  embryo 
showing magnification of PBI, (E) 48 hpf embryo showing strong expression anteriorly 
and  weaker  expression  in  the  rest  of  the  body,  (F)  48  hpf  embryo  showing 
magnification  of  the  head,  black  arrow  indicates  telencephalon,  blue  arrow  indicates 
myelencephalon,  red  arrow  indicates  endoderm,  (G)  48  hpf  embryo  at  dorsal  view 
showing expression along the midline, possible  lateral dorsal aorta  indicated by black 
arrow, possible dorsal aorta or notochord  indicated by blue arrow, expression  is also 
seen in the optic regions. 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Figure  11.  Whole‐mount  in  situ  hybridization  negative  controls.  Hybridization 
reactions were performed with sense (negative control) probes from cleavage period to 
hatching period. All embryos are absent of NBT/BCIP staining. (A) 2 hpf embryo, (B) 12 
hpf  embryo,  (C)  18  hpf  embryo,  (D)  24  hpf  embryo,  (E)  32  hpf  embryo,  (F)  36  hpf 
embryo, (G) 48 hpf embryo. 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Figure 12. Whole‐mount immunohistochemistry of abl expression. (A) 18 hpf embryo 
showing  expression  in  the  tail  bud  (tb),  (C)  24  hpf  showing  expression  within  the 
posterior  blood  island  (PBI)  indicated  by  black  arrow.  Red  arrows  show  expression 
within  the  tail,  blue  box  shows  the  PBI  at  higher  magnification.  (E)  32  hpf  embryo 
showing dark  staining within  the PBI,  (B,D,F) Negative  controls  at 18, 24,  and 32 hpf 
showing no abl expression. 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Figure 13. Western blot.  Quantified protein from K562 cells  and zebrafish at 18‐36 hpf 
were used. Yellow boxes indicate bands with correct molecular weight.  (A) Lane 1=18 
hpf, lane 2 =24 hpf, lane 3=32 hpf, lane 4=36 hpf, (B) Lane 1=K562, lane 2=18 hpf, lane 
3=24 hpf, lane 4=32 hpf, lane 5=36 hpf, (C) Pre‐absorbed negative control at 4:1 ratio of 
peptide to antibody, lane 1=K562, lane 2=18 hpf, lane 3=24 hpf, lane 4=32 hpf, lane 
5=36 hpf. 
 
 
 
 
 
 
 
 
 
 
 
 
 
44 
 
 
 
References 
 
Agami, R., Blandino, G., Oren, M., & Shaul, Y. (1999). Interaction of c-Abl and p73 alpha 
and their collaboration to induce apoptosis. Nature, 399, 809-813. 
Amar, M., Amit, M., Scoazec, J. Y., Pasquier, C., Babin-Chevaye, C., Pham Huu, T., . . . 
Hakim, J. (1992). K562 Cells Produce an Anti-Inflammatory Factor That Inhibits 
Neutrophil Functions In Vivo. Blood, 80, 1546-1552. 
Auer, R. L., Riaz, S., & Cotter, F. E. (2007). The 13q and 11q B-cell chronic lymphocytic 
leukaemia-associated regions derive from a common ancestral region in the zebrafish. 
British Journal of Haematology, 137, 443-453. 
Bertrand, J. Y., Kim, A. D., Violette, E. P., Stachura, D. L., Cisson, J. L., & Traver, D. 
(2007). Definitive hematopoiesis initiates through a committed erythromyeloid 
progenitor in the zebrafish embryo. Development, 134, 4147-4156. 
Boyle, S. N., Michaud, G. A., Schweitzer, B., Predki, P. F., & Koleske, A. J. (2007). A 
critical role for cortactin phosphorylation by Abl-family kinases in PDGF-induced 
dorsal-wave formation. Current Biology, 17, 445-451. 
Chen, J. H., Jette, C., Kanki, J. P., Aster, J., Look, A. T., & Griffin, J. D. (2006). NOTCH1-
induced T-cell leukemia in transgenic zebrafish. Blood, 108, 1825. 
Daley, G. Q., Vanetten, R. A., & Baltimore, D. (1990). Induction of chronic myelogenous 
leukemia in mice by the P210 BCR/ABL gene of the Philadelphia chromosome. 
Science, 247, 824-830. 
Davidson, A. J., & Zon, L. I. (2004). The 'definitive' (and 'primitive') guide to zebrafish 
hematopoiesis. Oncogene, 23, 7233-7246. 
Deming, P. B., Schafer, Z. T., Tashker, J. S., Potts, M. B., Deshmukh, M., & Kornbluth, S. 
(2004). Bcr-Abl-mediated protection from apoptosis downstream of mitochondrial 
cytochrome c release. Molecular and Cellular Biology, 24, 10289-10299. 
 
45 
Dereeper, A., Guignon, V., Blanc, G., Audic, S., Buffet, S., Chevenet, F., . . . Dufayard, J. F. 
(2008). Phylogeny.fr: robust phylogenetic analysis for the non-specialist. Nucleic 
Acids Research, 36, 465-469. 
Druker, B. J. (2008). Translation of the Philadelphia chromosome into therapy for CML. 
Blood, 112, 4808-4817. 
Feng, H., Langenau, D. M., Madge, J. A., Quinkertz, A., Gutierrez, A.,  & Neuberg, D. S. 
(2007). Heat-shock induction of T-cell lymphoma/leukaemia in conditional Cre/lox-
regulated transgenic zebrafish. British Journal of Haematology, 138, 169-175. 
Gong, J. G., Costanzo, A., Yang, H. Q., Melino, G., Kaelin, W. G., & Levrero, M. (1999). 
The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced 
DNA damage. Nature, 399, 806-809. 
Gross, A. W., & Ren, R. B. (2000). Bcr-Abl has a greater intrinsic capacity than v-Abl to 
induce the neoplastic expansion of myeloid cells. Oncogene, 19, 6286-6296. 
Henkemeyer, M., West, S. R., Gertler, F. B., & Hoffmann, F. M. (1990). A novel tyrosine 
kinase-independent function of Drosophila abl correlates with proper subcellular 
localization. Cell, 63, 949-960. 
Hsu, K., Traver, D., Kutok, J. L., Hagen, A., Liu, T. X., Paw, B. H., . . . Rhodes, J. (2004). 
The pu.1 promoter drives myeloid gene expression in zebrafish. Blood, 104, 1291-
1297. 
Huang, Y. P., Comiskey, E. O., Dupree, R. S., Li, S. X., Koleske, A. J., & Burkhardt, J. K. 
(2008). The c-Abl tyrosine kinase regulates actin remodeling at the immune synapse. 
Blood, 112, 111-119. 
Isogai, S., Horiguchi, M., & Weinstein, B. M. (2001). The vascular anatomy of the 
developing zebrafish: An atlas of embryonic and early larval development. 
Developmental Biology, 230, 278-301. 
Jin, H., Sood, R., Xu, J., Zhen, F., English, M. A., Liu, P. P., . . . Wen, Z. (2009). Definitive 
hematopoietic stem/progenitor cells manifest distinct differentiation output in the 
zebrafish VDA and PBI. Development, 136, 647-654. 
Kalev-Zylinska, M. L., Horsfield, J. A., Flores, M. V. C., Postlethwait, J. H., Vitas, M. R., 
Baas, A. M., . . . Crosier, P. S. (2002). Runx1 is required for zebrafish blood and 
 
46 
vessel development and expression of a human RUNX1-CBF2T1 transgene advances 
a model for studies of leukemogenesis. Development, 129, 2015-2030. 
Kimmel, C. B., Ballard, W. W., Kimmel, S. R., Ullmann, B., & Schilling, T. F. (1995). 
Stages of Embryonic-Development of the Zebrafish. Developmental Dynamics, 203, 
253-310. 
Koleske, A. J., Gifford, A. M., Scott, M. L., Nee, M., Bronson, R. T., Miczek, K. A., . . . 
Baltimore, D. (1998). Essential roles for the Abl and Arg tyrosine kinases in 
neurulation. Neuron, 21, 1259-1272. 
Kurzrock, R., Kantarjian, H. M., Druker, B. J., & Talpaz, M. (2003). Philadelphia 
chromosome-positive leukemias: From basic mechanisms to molecular therapeutics. 
Annals of Internal Medicine, 138, 819-830. 
Langenau, D. M., Traver, D., Ferrando, A. A., Kutok, J., Aster, J. C., Kanki, J. P., . . . Shuo, 
L. (2002). Myc-induced T-cell leukemia in transgenic zebrafish. Blood, 100, 110. 
Lapetina, S., Mader, C. C., Machida, K., Mayer, B. J., & Koleske, A. J. (2009). Arg interacts 
with cortactin to promote adhesion-dependent cell edge protrusion. Journal of Cell 
Biology, 185, 503-519. 
Lin, T. Y., Huang, C. H., Kao, H. H., Liou, G. G., Yeh, S. R., Cheng, C. M., . . . Pan, R. L. 
(2009). Abi plays an opposing role to Abl in Drosophila axonogenesis and 
synaptogenesis. Development, 136, 3099-3107. 
McGahon, A. J., Brown, D. G., Martin, S. J., AmaranteMendes, G. P., Cotter, T. G., Cohen, 
G. M., . . . Green, D. R. (1997). Downregulation of Bcr-Abl in K562 cells restores 
susceptibility to apoptosis: Characterization of the apoptotic death. Cell Death and 
Differentiation, 4, 95-104. 
Mebius, R. E., Miyamoto, T., Christensen, J., Domen, J., Cupedo, T., Weissman, I. L., . . . 
Akashi, K. (2001). The fetal liver counterpart of adult common lymphoid progenitors 
gives rise to all lymphoid lineages, CD45+CD4+CD3- cells, as well as macrophages. 
Journal of Immunology, 166, 6593-6601. 
Meeker, N. D., & Trede, N. S. (2008). Immunology and zebrafish: Spawning new models of 
human disease. Developmental and Comparative Immunology, 32, 745-757. 
 
47 
Murayama, E., Kissa, K., Zapata, A., Mordelet, E., Briolat, V., Lin, H. F., . . . Handin, R. I. 
(2006). Tracing hematopoietic precursor migration to successive hematopoietic 
organs during zebrafish development. Immunity, 25, 963-975. 
Murry, C. E., & Keller, G. (2008). Differentiation of embryonic stem cells to clinically 
relevant populations: Lessons from embryonic development. Cell, 132, 661-680. 
Nowell, P. C., & Hungerford, D. A. (1960). Minute Chromosome in Human Chronic 
Granulocytic Leukemia. Science, 132, 1497-1497. 
Orkin, S. H., & Zon, L. I. (2008). Hematopoiesis: An evolving paradigm for stem cell 
biology. Cell, 132, 631-644. 
Parham, P. (2005). The Immune System (2 ed.). New York, NY: Garland Science. 
Plattner, R., Kadlec, L., DeMali, K. A., Kazlauskas, A., & Pendergast, A. M. (1999). c-Abl is 
activated by growth factors and Src family kinases and has a role in the cellular 
response to PDGF. Genes & Development, 13, 2400-2411. 
Reinhold, U., Hennig, E., Leiblein, S., Niederwieser, D., & Deininger, M. W. N. (2003). 
FISH for BCR-ABL on interphases of peripheral blood neutrophils but not of 
unselected white cells correlates with bone marrow cytogenetics in CML patients 
treated with imatinib. Leukemia, 17, 1925-1929. 
Rowley, J. D. (1973). New Consistent Chromosomal Abnormality in Chronic Myelogenous 
Leukemia Identified by Quinacrine Fluorescence and Giemsa Staining. Nature, 243, 
290-293. 
Samokhvalov, I. M., Samokhvalova, N. I., & Nishikawa, S. (2007). Cell tracing shows the 
contribution of the yolk sac to adult haematopoiesis. Nature, 446, 1056-1061. 
Sharma, V. M., Calvo, J. A., Draheim, K. M., Cunningham, L. A., Hermance, N., Beverly, 
L., . . . Krishnamoorthy, V. (2006). Notch1 contributes to mouse T-cell leukemia by 
directly inducing the expression of c-myc. Molecular and Cellular Biology, 26, 8022-
8031. 
Shtivelman, E., Lifshitz, B., Gale, R. P., & Canaani, E. (1985). Fused transcript of Abl and 
Bcr genes in chronic myelogenous leukemia. Nature, 315, 550-554. 
Sipkins, D. A., Wei, X., Wu, J. W., Runnels, J. M., Cote, D., Means, T. K., . . . Luster, A. D. 
(2005). In vivo imaging of specialized bone marrow endothelial microdomains for 
tumour engraftment. Nature, 435, 969-973. 
 
48 
Sirvent, A., Benistant, C., & Roche, S. (2008). Cytoplasmic signalling by the c-Abl tyrosine 
kinase in normal and cancer cells. Biology of the Cell, 100, 617-631. 
Srinivasan, D., & Plattner, R. (2006). Activation of Abl tyrosine kinases promotes invasion 
of aggressive breast cancer cells. Cancer Research, 66, 5648-5655. 
Srinivasan, D., Sims, J. T., & Plattner, R. (2008). Aggressive breast cancer cells are 
dependent on activated Abl kinases for proliferation, anchorage-independent growth 
and survival. Oncogene, 27, 1095-1105. 
Stevens, T. L., Rogers, E. M., Koontz, L. M., Fox, D. T., Homem, C. C. F., Nowotarski, S. 
H., . . . Artabazon, N. B. (2008). Using Bcr-Abl to examine mechanisms by which 
Abl kinase regulates morphogenesis in Drosophila. Molecular Biology of the Cell, 19, 
378-393. 
Sun, X. G., Majumder, P., Shioya, H., Wu, F., Kumar, S., Weichselbaum, R., . . . Kharbanda, 
S. (2000). Activation of the cytoplasmic c-Abl tyrosine kinase by reactive oxygen 
species. Journal of Biological Chemistry, 275, 17237-17240. 
Thisse, C., & Thisse, B. (2008). High-resolution in situ hybridization to whole-mount 
zebrafish embryos. Nature Protocols, 3, 59-69. 
Tzeng, S. J., Bolland, S., Inabe, K., Kurosaki, T., & Pierce, S. K. (2005). The B cell 
inhibitory Fc receptor triggers apoptosis by a novel c-Abl family kinase-dependent 
pathway. Journal of Biological Chemistry, 280, 35247-35254. 
Ward, A. C., McPhee, D. O., Condron, M. M., Varma, S., Cody, S. H., Onnebo, S. M., . . . 
Paw, B. H. (2003). The zebrafish spi1 promoter drives myeloid-specific expression in 
stable transgenic fish. Blood, 102, 3238-3240. 
Weissman, I. L., Papaioannou, V., & Gardern, R.L. (1978). Fetal hematopoietic origins of 
the adult hematolymphoid system. Plainview, NY: Cold Spring Harbor Laboratory 
press. 
Wetzler, M., Talpaz, M., Van Etten, R. A., Hirsh-Ginsberg, C., Beran, M., & Kurzrock, R. 
(1993). Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and 
leukemic cells and correlation of expression with myeloid differentiation. Journal of 
Clinical Investigation, 92, 1925-1939. 
 
49 
Willett, C. E., Cortes, A., Zuasti, A., & Zapata, A. G. (1999). Early hematopoiesis and 
developing lymphoid organs in the zebrafish. Developmental Dynamics, 214, 323-
336. 
Yoder, J. A., Nielsen, M. E., Amemiya, C. T., & Litman, G. W. (2002). Zebrafish as an 
immunological model system. Microbes and Infection, 4, 1469-1478. 
Yoshihara, H., Arai, F., Hosokawa, K., Hagiwara, T., Takubo, K., Nakamura, Y., . . . Gomei, 
Y. (2007). Thrombopoietin/MPL signaling regulates hematopoietic stem cell 
quiescence and interaction with the osteoblastic niche. Cell Stem Cell, 1, 685-697. 
Zapata, A., Diez, B., Cejalvo, T., Frias, C. G., & Cortes, A. (2006). Ontogeny of the immune 
system of fish. Fish & Shellfish Immunology, 20, 126-136. 
Zhuravleva, J., Paggetti, J., Martin, L., Hammann, A., Solary, E., Bastie, J. N.,  . . . Delva, L. 
(2008). MOZ/TIF2-induced acute myeloid leukaemia in transgenic fish. British 
Journal of Haematology, 143, 378-382. 
Zipfel, P. A., Zhang, W. G., Quiroz, M., & Pendergast, A. M. (2004). Requirement for Abl 
kinases in T cell receptor signaling. Current Biology, 14, 1222-1231. 
 
 
 
  50 
 
 
 
BIOGRAPHICAL SKETCH 
  Born the first of three sons to Richard and Nora de Triquet on August 5th, 1986 at 
Ft. Belvoir, Virginia, Ricky de Triquet has spent much of his life traveling. With a father in 
the Marines,  he was  afforded  the  experience  of multiple  cross‐country  drives  and  trans‐
pacific  flights before ten years of age. The hardwood forests of  the Pacific Northwest,  the 
jungles of Southeast Asia, the chaparral of the southern California, and the peanut farms of 
Suffolk,  Virginia  name  just  a  few  of  his  homes.  This  myriad  of  locales  gives  him  a  rare 
perspective  of  the  globe’s  diverse  cultures,  cuisine,  and  ecosystems  that  he  is  forever 
grateful  for.  Ricky  attended  Belmont  Abbey  College  where  he  joined  the  men’s  varsity 
soccer team and earned a Bachelor of Science in Biology.  
  His graduate research, involving a cancer causing protein, is an inherent interest of 
his  born  by  personal  experiences;  he  hopes  that  publication  will  add  to  the  current 
momentum  in  favor  of  cancer  therapy.  At  this  stage  in  his  career,  he  looks  toward  the 
future to continue his education in many areas, not just science, and knows that he will be a 
lifelong learner.  
  
 
